Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

TRABECTEDIN

TRABECTEDIN

Standard Dose
1MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary

Approval overview TRABECTEDIN is listed in Drugs@FDA under application 214837 (ANDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient TRABECTEDIN Form and strength INJECTABLE;INJECTION - 1MG Sponsor NATCO PHARMA LTD Submission history Latest submission status date: 2022-08-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRABECTEDIN is listed in Drugs@FDA under application 214837 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient TRABECTEDIN Form and strength INJECTABLE;INJECTION - 1MG Sponsor NATCO PHARMA LTD Submission history Latest submission status date: 2022-08-10 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.